(Reuters) -Healthcare company Medline is weighing a public filing for an initial public offering as soon as late October, Bloomberg News reported on Wednesday, citing people familiar with the matter.

The IPO could raise about $5 billion and value the company at as much as $50 billion, according to the report.

U.S. IPO activity has picked up in recent months, as recent listings attracted strong investor interest, reversing a slowdown earlier in the year due to trade-policy uncertainty.

Goldman Sachs and Morgan Stanley are leading the banks working on the offering, Bloomberg News reported.

Medline did not immediately respond to a Reuters request for comment.

(Reporting by Prakhar Srivastava in Bengaluru; Editing by Krishna Chandra Eluri and Shinjini Ganguli)

See Full Page